.png){kind=icon}
返回
Glioma
.png){kind=icon}
PRE
AI
DOI：10.1038/nrdp.2015.17.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Gliomas are primary brain tumours that are thought to derive from neuroglial stem or progenitor cells. On the basis of their histological appearance, they have been traditionally classified as astrocytic, oligodendroglial or ependymal tumours and assigned WHO grades I-IV, which indicate different degrees of malignancy. Tremendous progress in genomic, transcriptomic and epigenetic profiling has resulted in new concepts of classifying and treating gliomas. Diffusely infiltrating gliomas in adults are now separated into three overarching tumour groups with distinct natural histories, responses to treatment and outcomes: isocitrate dehydrogenase (IDH)-mutant, 1p/19q co-deleted tumours with mostly oligodendroglial morphology that are associated with the best prognosis; IDH-mutant, 1p/19q non-co-deleted tumours with mostly astrocytic histology that are associated with intermediate outcome; and IDH wild-type, mostly higher WHO grade (III or IV) tumours that are associated with poor prognosis. Gliomas in children are molecularly distinct from those in adults, the majority being WHO grade I pilocytic astrocytomas characterized by circumscribed growth, favourable prognosis and frequent BRAF gene fusions or mutations. Ependymal tumours can be molecularly subdivided into distinct epigenetic subgroups according to location and prognosis. Although surgery, radiotherapy and alkylating agent chemotherapy are still the mainstay of treatment, individually tailored strategies based on tumour-intrinsic dominant signalling pathways and antigenic tumour profiles may ultimately improve outcome. For an illustrated summary of this Primer, visit: http://go.nature.com/TXY7Ri
Keyword:
LOW-GRADE GLIOMA
CENTRAL-NERVOUS-SYSTEM
RANDOMIZED PHASE-III
NEWLY-DIAGNOSED GLIOBLASTOMA
RESPONSE ASSESSMENT CRITERIA
MGMT PROMOTER METHYLATION
MAPK PATHWAY ACTIVATION
GENOME-WIDE ASSOCIATION
GROWTH-FACTOR RECEPTOR
EORTC BRAIN-TUMOR
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
N
IF:
60.6
论文数:
649
被引数:
3.8W
机构
引用论文
分享收藏Entanglement transport and a nanophotonic interface for atoms in optical tweezers光镊中原子的纠缠传输和纳米光子界面.png)
Science
OAAI
ScienceIF0
OAAI分享收藏Primary Central Nervous System Lymphoma and Atypical Glioblastoma: Multiparametric Differentiation by Using Diffusion-, Perfusion-, and Susceptibility-weighted MR ImagingRADIOLOGY
RADIOLOGYIF15.2
PREAI
分享收藏BRAF Activation Induces Transformation and Then Senescence in Human Neural Stem Cells: A Pilocytic Astrocytoma ModelCLINICAL CANCER RESEARCH
OAAI
CLINICAL CANCER RESEARCHIF10.2
OAAI分享收藏
查看更多内容